Dr. John Dequardo, M.D

NPI: 1679500219
Total Payments
$17,019
2020 Payments
$35.17
Companies
8
Transactions
22

Payment Breakdown by Category

Consulting$15,120 (88.8%)
Food & Beverage$1,050 (6.2%)
Travel$835.81 (4.9%)
Education$13.62 (0.1%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $15,120 2 88.8%
Food and Beverage $1,050 16 6.2%
Travel and Lodging $835.81 3 4.9%
Education $13.62 1 0.1%

Top Paying Companies

Company Total Records Latest Year
Alkermes, Inc. $16,484 9 $0 (2019)
Neurocrine Biosciences, Inc. $132.33 4 $0 (2020)
Sunovion Pharmaceuticals Inc. $123.91 1 $0 (2018)
Janssen Scientific Affairs, LLC $101.40 1 $0 (2018)
Otsuka America Pharmaceutical, Inc. $79.18 3 $0 (2019)
Allergan Inc. $50.00 1 $0 (2019)
Vanda Pharmaceuticals Inc. $33.51 2 $0 (2019)
Teva Pharmaceuticals USA, Inc. $14.97 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2020 $35.17 1 Neurocrine Biosciences, Inc. ($35.17)
2019 $16,554 11 Alkermes, Inc. ($16,390)
2018 $430.26 10 Sunovion Pharmaceuticals Inc. ($123.91)

All Payment Transactions

22 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
01/08/2020 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $35.17 General
Category: NEUROLOGY
09/18/2019 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $52.00 General
Category: CNS
07/24/2019 Allergan Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $50.00 General
Category: NEUROSCIENCE
07/01/2019 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Consulting Fee Cash or cash equivalent $7,560.00 General
Category: CNS
05/31/2019 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Consulting Fee Cash or cash equivalent $7,560.00 General
Category: CNS
05/31/2019 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Travel and Lodging In-kind items and services $531.50 General
Category: CNS
05/31/2019 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $382.15 General
Category: CNS
05/31/2019 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Travel and Lodging In-kind items and services $169.86 General
Category: CNS
05/31/2019 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Travel and Lodging In-kind items and services $134.45 General
Category: CNS
05/23/2019 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $50.00 General
Category: PSYCHIATRY
05/15/2019 Vanda Pharmaceuticals Inc. Fanapt (Drug) Education Cash or cash equivalent $13.62 General
Category: Schizophrenia
01/10/2019 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $50.24 General
Category: NEUROLOGY
12/13/2018 Vanda Pharmaceuticals Inc. Fanapt (Drug) Food and Beverage In-kind items and services $19.89 General
Category: Schizophrenia
11/28/2018 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug) Food and Beverage In-kind items and services $13.78 General
Category: PSYCHIATRY
11/15/2018 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $123.91 General
Category: CNS
11/07/2018 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $12.69 General
Category: NEUROLOGY
07/26/2018 Alkermes, Inc. Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg Food and Beverage In-kind items and services $44.00 General
Category: CNS
05/16/2018 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug) Food and Beverage In-kind items and services $15.40 General
Category: PSYCHIATRY
04/05/2018 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) Food and Beverage In-kind items and services $14.97 General
Category: Central Nervous System
04/04/2018 Alkermes, Inc. Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg Food and Beverage In-kind items and services $49.99 General
Category: CNS
03/28/2018 Janssen Scientific Affairs, LLC INVEGA TRINZA (Drug) Food and Beverage In-kind items and services $101.40 General
Category: Neuroscience
02/20/2018 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $34.23 General
Category: NEUROLOGY

About Dr. John Dequardo, M.D

Dr. John Dequardo, M.D is a Psychiatry healthcare provider based in Pueblo, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679500219.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Dequardo, M.D has received a total of $17,019 in payments from pharmaceutical and medical device companies, with $35.17 received in 2020. These payments were reported across 22 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($15,120).

Practice Information

  • Specialty Psychiatry
  • Location Pueblo, CO
  • Active Since 06/27/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • NPI Number 1679500219

Products in Payments

  • ARISTADA (Drug) $16,390
  • INGREZZA (Drug) $132.33
  • LATUDA (Drug) $123.91
  • INVEGA TRINZA (Drug) $101.40
  • Aristada 441 mg (Drug) $93.99
  • REXULTI (Drug) $50.00
  • VRAYLAR (Drug) $50.00
  • Fanapt (Drug) $33.51
  • ABILIFY MAINTENA (Drug) $29.18
  • AUSTEDO (Drug) $14.97

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Pueblo